Ewa Czarnobilska
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ewa Czarnobilska has a total of 74 co-authors. Here are the top co-authors by number of shared publications:
- Dorota Myszkowska
Department of Clinical and Environmental Allergology, Jagiellonian University Medical College, Krakow, Poland
3 shared publications - Monika Ziemianin
Department of Clinical and Environmental Allergology, Medical College, Jagiellonian University, Botaniczna 3, Kraków, 31-503, Poland
2 shared publications - Agnieszka Kubik-Komar
Department of Applied Mathematics and Computer Science, University of Life Sciences in Lublin, Lublin, Poland
1 shared publication Agnieszka Lis
1 shared publicationAleksandra Wilkowska
1 shared publicationAleksandra Łata
1 shared publication
Latest Publications
- Open Access
Influence of Environmental Pollution on Basophil Reactivity to Birch Pollen Allergens in Atopic and Non‐Atopic Subjects
Background: Sensitization to birch pollen is a major contributor to allergic rhinitis in Europe, with sensitization rates in many countries from 10% to 20% of the general population. Growing evidence suggests that air pollution enhances the allergenicity of pollen; however, the clinical consequences of this co‐exposure remain poorly understood. This study investigated whether air pollution intensifies birch pollen allergenicity and assessed its effects on symptom severity and basophil activation in allergic and non‐allergic individuals. Methods: Fifty birch‐allergic patients and twenty‐five non‐atopic controls were examined over two consecutive pollen seasons (2023–2024). Daily nasal, ocular, and asthma symptoms were recorded using a mobile application. Ambient air pollutants (PM 2.5 , PM 10 , and O 3 ) and birch pollen concentrations were continuously monitored in Kraków. Basophil activation tests (BAT) were performed using commercial birch pollen extracts, Bet v1 allergen, and natural pollen collected from highly and less polluted areas. Basophil activation was quantified by CD63 expression using flow cytometry. Results: Asthmatic symptoms showed significant positive correlations with both birch pollen and PM concentrations ( p < 0.05), especially in 2023. Pollen collected from polluted sites induced significantly stronger basophil activation compared with pollen from less polluted areas ( p < 0.0001). The magnitude of basophil activation correlated with serum IgE levels to birch and Bet v 1, as well as with clinical symptom scores. Conclusions: Air pollution enhances the allergenic potency of birch pollen, resulting in heightened basophil activation and more severe allergic symptoms. These findings highlight the importance of integrating air pollution monitoring alongside pollen surveillance when assessing allergic disease burden and evaluating the effectiveness of allergen immunotherapy.
Open AccessInfluence of Environmental Pollution on Basophil Reactivity to Birch Pollen Allergens in Atopic and Non‐Atopic Subjects
Background: Sensitization to birch pollen is a major contributor to allergic rhinitis in Europe, with sensitization rates in many countries from 10% to 20% of the general population. Growing evidence suggests that air pollution enhances the allergenicity of pollen; however, the clinical consequences of this co‐exposure remain poorly understood. This study investigated whether air pollution intensifies birch pollen allergenicity and assessed its effects on symptom severity and basophil activation in allergic and non‐allergic individuals. Methods: Fifty birch‐allergic patients and twenty‐five non‐atopic controls were examined over two consecutive pollen seasons (2023–2024). Daily nasal, ocular, and asthma symptoms were recorded using a mobile application. Ambient air pollutants (PM 2.5 , PM 10 , and O 3 ) and birch pollen concentrations were continuously monitored in Kraków. Basophil activation tests (BAT) were performed using commercial birch pollen extracts, Bet v1 allergen, and natural pollen collected from highly and less polluted areas. Basophil activation was quantified by CD63 expression using flow cytometry. Results: Asthmatic symptoms showed significant positive correlations with both birch pollen and PM concentrations ( p < 0.05), especially in 2023. Pollen collected from polluted sites induced significantly stronger basophil activation compared with pollen from less polluted areas ( p < 0.0001). The magnitude of basophil activation correlated with serum IgE levels to birch and Bet v 1, as well as with clinical symptom scores. Conclusions: Air pollution enhances the allergenic potency of birch pollen, resulting in heightened basophil activation and more severe allergic symptoms. These findings highlight the importance of integrating air pollution monitoring alongside pollen surveillance when assessing allergic disease burden and evaluating the effectiveness of allergen immunotherapy.
- Open Access
- 13 February 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1) , 6182
Possible implications of the variability of the most allergenic plant pollen seasons in Poland
The online version contains supplementary material available at 10.1038/s41598-026-36159-0.
- 13 February 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1) , 6182
Open AccessPossible implications of the variability of the most allergenic plant pollen seasons in Poland
The online version contains supplementary material available at 10.1038/s41598-026-36159-0.
- Open Access
- 30 November 2021
- Published by Medical Education in Alergoprofil
- Vol. 17 (4) , 3-11
Immunoterapia na jad owadów błonkoskrzydłych – kiedy i kogo kwalifikować do leczenia
Alergia na jad owadów błonkoskrzydłych to najczęstsza przyczyna wstrząsu anafilaktycznego u dorosłych, a druga po alergii pokarmowej u dzieci. W warunkach polskich najczęstszymi przyczynami alergii są użądlenia przez pszczoły miodne (Apis mellifera), osy (Vespula spp.) oraz szerszenie (Vespa spp., częściej u osób już wcześniej żądlonych przez osy). Skutkiem użądlenia jest zazwyczaj odczyn miejscowy, jednak ok. 3% dorosłych i 0,5% dzieci reaguje odczynami ogólnoustrojowymi o charakterze anafilaksji. Diagnostyka nadwrażliwości na jady bywa trudna, szczególnie gdy wywiad nie wskazuje jednoznacznie na owada sprawczego. Jej podstawą są testy skórne z jadem osy i pszczoły: punktowe (prick test) i śródskórne o łącznej czułości 94%, i oznaczenie poziomu specyficznych IgE, których czułość wynosi od 83% do 100%. Postawą leczenia jest immunoterapia swoista, do której są kwalifikowani pacjenci z ciężkimi reakcjami anafilaktycznymi i udowodnionym mechanizmem IgE-zależnym alergii. W wyjątkowych sytuacjach do leczenia są kwalifikowane osoby z dużymi odczynami miejscowymi narażone na częste użądlenia z racji wykonywanej pracy oraz z izolowanymi zmianami skórnymi, które znacznie obniżają jakość ich życia. Immunoterapia swoista jest jedyną skuteczną metodą leczenia, trwa 3–5 lat, a jej skuteczność wynosi 91–96% przy alergii na jad osy oraz 77–84% przy alergii na jad pszczoły.
- 30 November 2021
- Published by Medical Education in Alergoprofil
- Vol. 17 (4) , 3-11
Open AccessImmunoterapia na jad owadów błonkoskrzydłych – kiedy i kogo kwalifikować do leczenia
Alergia na jad owadów błonkoskrzydłych to najczęstsza przyczyna wstrząsu anafilaktycznego u dorosłych, a druga po alergii pokarmowej u dzieci. W warunkach polskich najczęstszymi przyczynami alergii są użądlenia przez pszczoły miodne (Apis mellifera), osy (Vespula spp.) oraz szerszenie (Vespa spp., częściej u osób już wcześniej żądlonych przez osy). Skutkiem użądlenia jest zazwyczaj odczyn miejscowy, jednak ok. 3% dorosłych i 0,5% dzieci reaguje odczynami ogólnoustrojowymi o charakterze anafilaksji. Diagnostyka nadwrażliwości na jady bywa trudna, szczególnie gdy wywiad nie wskazuje jednoznacznie na owada sprawczego. Jej podstawą są testy skórne z jadem osy i pszczoły: punktowe (prick test) i śródskórne o łącznej czułości 94%, i oznaczenie poziomu specyficznych IgE, których czułość wynosi od 83% do 100%. Postawą leczenia jest immunoterapia swoista, do której są kwalifikowani pacjenci z ciężkimi reakcjami anafilaktycznymi i udowodnionym mechanizmem IgE-zależnym alergii. W wyjątkowych sytuacjach do leczenia są kwalifikowane osoby z dużymi odczynami miejscowymi narażone na częste użądlenia z racji wykonywanej pracy oraz z izolowanymi zmianami skórnymi, które znacznie obniżają jakość ich życia. Immunoterapia swoista jest jedyną skuteczną metodą leczenia, trwa 3–5 lat, a jej skuteczność wynosi 91–96% przy alergii na jad osy oraz 77–84% przy alergii na jad pszczoły.
- Open Access
- 25 March 2021
- Published by Springer Nature in Environmental Science and Pollution Research
- Vol. 28 (29) , 39952-39965
Changes in qualitative and quantitative traits of birch (Betula pendula) pollen allergenic proteins in relation to the pollution contamination
Birch (Betula pendula) pollen causes inhalant allergy in about 20% of human population in Europe, most of which is sensitive to the main birch allergen, Bet v1. The aim of the study was to find out (i) whether and how the analysed birch individuals differ in regard to composition of individual subunits of pollen proteins and to protein content in these subunits; (ii) whether the level of particulate matter relates to concentration of Bet v1 allergen. Study was performed in Southern Poland, in 2017–2019. Pollen material was collected at 20 sites, of highly or less polluted areas. Protein composition was analysed by SDS-PAGE, while the concentration of Bet v1 was evaluated by ELISA. The obtained results were estimated at the background of the particulate matter (PM10) level and the birch pollen seasons in Kraków. The electrophoregrams of pollen samples collected at different sites showed huge differences in staining intensities of individual protein subunits, also among important birch allergens: Bet v1, Bet v2, Bet v6 and Bet v7. The level of Bet v1 was significantly higher in the pollen samples collected at the more polluted sites. While the birch pollen allergenic potential is determined, the both pollen exposure and the content of the main allergenic components should be considered, as factors causing immunological response and clinical symptoms manifestation in sensitive individuals.
- 25 March 2021
- Published by Springer Nature in Environmental Science and Pollution Research
- Vol. 28 (29) , 39952-39965
Open AccessChanges in qualitative and quantitative traits of birch (Betula pendula) pollen allergenic proteins in relation to the pollution contamination
Birch (Betula pendula) pollen causes inhalant allergy in about 20% of human population in Europe, most of which is sensitive to the main birch allergen, Bet v1. The aim of the study was to find out (i) whether and how the analysed birch individuals differ in regard to composition of individual subunits of pollen proteins and to protein content in these subunits; (ii) whether the level of particulate matter relates to concentration of Bet v1 allergen. Study was performed in Southern Poland, in 2017–2019. Pollen material was collected at 20 sites, of highly or less polluted areas. Protein composition was analysed by SDS-PAGE, while the concentration of Bet v1 was evaluated by ELISA. The obtained results were estimated at the background of the particulate matter (PM10) level and the birch pollen seasons in Kraków. The electrophoregrams of pollen samples collected at different sites showed huge differences in staining intensities of individual protein subunits, also among important birch allergens: Bet v1, Bet v2, Bet v6 and Bet v7. The level of Bet v1 was significantly higher in the pollen samples collected at the more polluted sites. While the birch pollen allergenic potential is determined, the both pollen exposure and the content of the main allergenic components should be considered, as factors causing immunological response and clinical symptoms manifestation in sensitive individuals.
- Open Access
- 30 November 2016
- Published by "Medycyna Praktyczna" Spolka Jawna in Polish Archives of Internal Medicine
- Vol. 126 (11) , 904
Basophil activation test in allergic rhinitis. Authors' reply.
- 30 November 2016
- Published by "Medycyna Praktyczna" Spolka Jawna in Polish Archives of Internal Medicine
- Vol. 126 (11) , 904
Open AccessBasophil activation test in allergic rhinitis. Authors' reply.